News & Updates
Filter by Specialty:
Intensive weight-loss does not improve outcomes in obese NAFLD patients
An intensive weight-loss intervention has failed to substantially improve the treatment outcomes among obese patients with nonalcoholic fatty liver disease (NAFLD), reports a recent study.
Intensive weight-loss does not improve outcomes in obese NAFLD patients
22 Sep 2022
Frequent diet education, delivered by dietitians, helps improve diet in T2D patients
Patients with type 2 diabetes (T2D) can benefit from a dietitian-led intensive dietary intervention, including frequent dietary education, which helps promote more healthful eating patterns, a recent study has found.
Frequent diet education, delivered by dietitians, helps improve diet in T2D patients
20 Sep 2022
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
The presence of erectile dysfunction (ED) does not appear to confer an increased risk of cardiovascular disease (CVD) and mortality in men with diabetes mellitus (DM), with comparable risk of adverse cardiovascular events among users and nonusers of phosphodiesterase-5 inhibitors (PDE5-Is), which are used to manage ED, according to a study.
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
20 Sep 2022
Does diabetes worsen survival in metastatic breast cancer?
Diabetes does not appear to increase mortality in patients with metastatic breast cancer (MBC), but diabetes and hyperglycaemia both contribute to worse overall survival (OS) in a cohort of longer-term survivors, a study has found.
Does diabetes worsen survival in metastatic breast cancer?
19 Sep 2022
SGLT2 inhibitors help prevent new-onset AF in diabetic Asians
Use of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may reduce the risk of new-onset atrial fibrillation (AF) relative to glucagon-like peptide-1 receptor agonists (GLP-1RAs) in Asian patients with type 2 diabetes mellitus (T2DM) in a real-world practice, reports a recent study.
SGLT2 inhibitors help prevent new-onset AF in diabetic Asians
18 Sep 2022
COVID-19 lockdown weakens metabolism in people with glucose intolerance
In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.
COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022
Insulin glargine, degludec yield comparable effects on glycaemic control
In patients with of type 2 diabetes (T2D), glargine 300 U/mL (Gla-300) and degludec 100 U/mL (Deg-100) deliver similar improvements in glycaemic control, without increasing weight and hypoglycaemic events over 6 months of treatment, according to data from the retrospective RESTORE-2 NAIVE study.
Insulin glargine, degludec yield comparable effects on glycaemic control
09 Sep 2022
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
A post hoc analysis of the SUSTAIN 6 and PIONEER 6 trials has found that semaglutide reduces incidence of any stroke in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk vs placebo.